病毒学报
病毒學報
병독학보
CHINESE JOURNAL OF VIROLOGY
2001年
1期
38-42
,共5页
张军%王颖彬%徐颖潇%逄淑强%张国忠%杨海杰%夏宁邵
張軍%王穎彬%徐穎瀟%逄淑彊%張國忠%楊海傑%夏寧邵
장군%왕영빈%서영소%방숙강%장국충%양해걸%하저소
人类T淋巴细胞白血病病毒%膜基因%原核表达%抗原
人類T淋巴細胞白血病病毒%膜基因%原覈錶達%抗原
인류T림파세포백혈병병독%막기인%원핵표체%항원
为尽快研制出国产HTLV抗体诊断试剂,首先从福建HTLV流行区1名HTLV感染者外周血细胞中克隆出HTLV-Ⅰ的全长膜基因(env),继而结合文献报道、PSA软件的亲疏水性分析和EPI软件的B细胞表位分析数据,选择了gp46中段开始延伸至gp21N端212个氨基酸(aa185~aa396)的基因,并在3′端通过(GlySer)2与人工合成的HTLV-Ⅱ型的型特异性表位区基因嵌合,插入原核表达载体pRSET,在E.coli中得到了高效表达,目的蛋白产量约占菌体总蛋白的30%。通过Triton-X100洗涤,低浓度尿素逐步变性处理,8mol/L尿素溶解后纯度在75%左右,经电泳洗脱纯化,最终纯度可达95%左右,纯蛋白得率约40%。经Westernblotting检测,该蛋白对4份HTLV-Ⅰ型和2份HTLV-Ⅱ型血清均有较强反应,而对4份阴性血清无反应,从而有可能用于研制HTLV抗体诊断试剂盒。
為儘快研製齣國產HTLV抗體診斷試劑,首先從福建HTLV流行區1名HTLV感染者外週血細胞中剋隆齣HTLV-Ⅰ的全長膜基因(env),繼而結閤文獻報道、PSA軟件的親疏水性分析和EPI軟件的B細胞錶位分析數據,選擇瞭gp46中段開始延伸至gp21N耑212箇氨基痠(aa185~aa396)的基因,併在3′耑通過(GlySer)2與人工閤成的HTLV-Ⅱ型的型特異性錶位區基因嵌閤,插入原覈錶達載體pRSET,在E.coli中得到瞭高效錶達,目的蛋白產量約佔菌體總蛋白的30%。通過Triton-X100洗滌,低濃度尿素逐步變性處理,8mol/L尿素溶解後純度在75%左右,經電泳洗脫純化,最終純度可達95%左右,純蛋白得率約40%。經Westernblotting檢測,該蛋白對4份HTLV-Ⅰ型和2份HTLV-Ⅱ型血清均有較彊反應,而對4份陰性血清無反應,從而有可能用于研製HTLV抗體診斷試劑盒。
위진쾌연제출국산HTLV항체진단시제,수선종복건HTLV류행구1명HTLV감염자외주혈세포중극륭출HTLV-Ⅰ적전장막기인(env),계이결합문헌보도、PSA연건적친소수성분석화EPI연건적B세포표위분석수거,선택료gp46중단개시연신지gp21N단212개안기산(aa185~aa396)적기인,병재3′단통과(GlySer)2여인공합성적HTLV-Ⅱ형적형특이성표위구기인감합,삽입원핵표체재체pRSET,재E.coli중득도료고효표체,목적단백산량약점균체총단백적30%。통과Triton-X100세조,저농도뇨소축보변성처리,8mol/L뇨소용해후순도재75%좌우,경전영세탈순화,최종순도가체95%좌우,순단백득솔약40%。경Westernblotting검측,해단백대4빈HTLV-Ⅰ형화2빈HTLV-Ⅱ형혈청균유교강반응,이대4빈음성혈청무반응,종이유가능용우연제HTLV항체진단시제합。
For development of an antibody detection reagent for humanT-lymphotropic virus (HTLV), a full-length envelope(env) gene of HTLV type Ⅰ (HTLV-I) was cloned from peripheral blood cells of a HTLV-Ⅰ infected individual in a HTLV endemic region of Fujian, and then a gene fragment of 212 amino acid length from the midpiece of gp46 extending to the N-terminal of gp21 was selected as well as a type specific epitope region of HTLV type Ⅱ env gene to construct a HTLV Ⅰ+Ⅱ chimeric gene. This chimeric fragment was inserted into prokaryotic expression vector pRSET and expressed in E. coli. The yield of the target recombinant protein was about 30%. The final purity is about 95% after electrophoresis elution purification. Detected by Western blotting, this recombinant protein showed strong reaction with four HTLV-Ⅰ positive sera as well as two HTLV-Ⅱ positive sera, and had no response to four HTLV negative sera. Thus, this recombinant antigen can be used to develop a diagnostic reagent for HTLV antibody detection.